Can I read 7100 20 KRAS G12D Vs 7375 Verastem Oncology Tumor Preclinical on-OfF Inhibitor Coma on EtoBox?
7100 20 KRAS G12D Vs 7375 Verastem Oncology Tumor Preclinical on-OfF Inhibitor Coma by Jaya Kumar is a document available to read on EtoBox.
What is 7100 20 KRAS G12D Vs 7375 Verastem Oncology Tumor Preclinical on-OfF Inhibitor Coma about?
VS-7375 is an oral, selective dual inhibitor of KRAS G12D, showing potent anti-tumor activity in various cancer models. It effectively suppresses KRAS G12D signaling in both ON and OFF states, outperforming existing inhibitors, and demonstrates durable efficacy in combination with other therapies. Ongoing clinical evaluations in the US and China aim to assess its potential for treating patients with KRAS G12D-mutated cancers.
- Author
- Jaya Kumar
- Language
- EN